Prevalence of glaucoma in the Israeli Arab population

Otzem Chassid, Irena Epstein, Adi Sharabi-Nov, Joseph Pikkel

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

We describe the prevalence and treatment of glaucoma in a Muslim Arab population in Israel. Based on the medical records of 15 122 persons, the overall prevalence of glaucoma was 3.9%. Prevalence rates of primary open angle glaucoma (POAG) and primary angle-closure glaucoma (PACG) were 3.0% and 0.42%, respectively. Prevalence rates of women were 135% that of men considering all types of glaucoma, 143% for POAG, and 96% for PACG. Prostaglandin analogs and beta blockers, alone or combined with carbonic anhydrase inhibitors, were the preferred medications. Of 68 patients who underwent trabeculectomy, 27 (39.7%) required medications, postoperatively, for treatment of glaucoma; following Ex-Press shunt surgery, 3/11 (27.3%) required medications. During the last three years, 16 (1.3%) individuals with POAG were recorded as legally blind as a result of glaucoma.

Original languageEnglish
Pages (from-to)163-165
Number of pages3
JournalInternational Journal of Ophthalmology
Volume11
Issue number1
DOIs
StatePublished - 18 Jan 2018
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2018, International Journal of Ophthalmology (c/o Editorial Office). All rights reserved.

Funding

1Research support from the Social Sciences and Humanities Research Council of Canada is gratefully acknowledged. The paper was presented at the University of Southampton. We thank seminar participants for their comments and criticisms and we are especially indebted to Peter Vallentyne for comments on two earlier drafts.

FundersFunder number
Social Sciences and Humanities Research Council of Canada

    Keywords

    • Arab
    • Beta-blockers
    • Glaucoma
    • Trabeculectomy

    Fingerprint

    Dive into the research topics of 'Prevalence of glaucoma in the Israeli Arab population'. Together they form a unique fingerprint.

    Cite this